transferrin has been researched along with Thyroid Nodule in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bountouris, P; Mamali, I; Markantes, GK; Markou, KB; Michalaki, MA | 1 |
| Schlechte, JA | 1 |
2 other study(ies) available for transferrin and Thyroid Nodule
| Article | Year |
|---|---|
Benign thyroid nodules respond to a single administration of 0.3mg recombinant human thyrotropin with highly variable volume increase.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Thyroid Nodule; Thyrotropin; Thyrotropin Alfa; Thyroxine | 2022 |
Update in endocrinology: evidence published in 2012.
Topics: Biliopancreatic Diversion; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diphosphonates; Fatty Acids, Omega-3; Female; Fractures, Bone; Gastrectomy; Gastric Bypass; Gene Expression; Gene Expression Profiling; Glucose Intolerance; Hip Fractures; Humans; Hypoglycemic Agents; Imidazoles; Insulin, Long-Acting; Iodine Radioisotopes; Male; Metformin; Obesity; Obesity, Morbid; Osteoporosis; Spinal Fractures; Thiazolidinediones; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Thyrotropin; Thyrotropin Alfa; Vitamin D | 2013 |